Chloe Braud

Chloe Braud, as Regulatory Affairs Manager - New Markets at BeiGene, plays a pivotal role in driving the company's expansion into emerging regions, with a particular focus on the MENA (Middle East and North Africa) region. Leveraging her Pharm.D. background and advanced expertise in international drug development and registration from Paris Sud University, Chloe expertly navigates complex regulatory landscapes to ensure seamless market access for BeiGene’s innovative oncology and immunotherapy products. Her current role involves meticulous planning and coordination of regulatory submissions, including dossiers for drug registration, variations, and renewals, tailored to meet the specific requirements of diverse regulatory authorities within the MENA region.

Chloe’s strategic guidance on regulatory tactics is instrumental in aligning BeiGene’s global objectives with regional compliance standards, facilitating timely approvals and maintaining product lifecycle management. She collaborates closely with cross-functional teams—including clinical development, quality assurance, and commercial operations—to develop robust regulatory strategies that optimize market entry and sustainability. Her expertise in biotechnology, sciences de la vie, and pharmaceutical industry practices, combined with her proficiency in labelling and health services, ensures that BeiGene’s products adhere to high standards of safety, efficacy, and regulatory compliance.

Moreover, Chloe’s skills in project management and client service enable her to effectively communicate complex regulatory information to stakeholders and regulatory authorities, fostering strong relationships and ensuring transparency throughout the registration process. Her ability to speak publicly and present regulatory strategies confidently further enhances her role as a key liaison in BeiGene’s global regulatory affairs team. Through her dedicated efforts, Chloe is instrumental in advancing BeiGene’s mission to bring innovative cancer therapies to patients worldwide, particularly in regions with evolving regulatory frameworks.